Security key
803607100
Sarepta Therapeutics, Inc. - Common Stock (SRPT)
CUSIP: 803607100
Q1 2020 13F Holders as of 31 Mar 2020
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 105,070,763
- Total 13F shares
- 73,412,115
- Share change
- +133,711
- Total reported value
- $7,179,418,082
- Put/Call ratio
- 132%
- Price per share
- $97.82
- Number of holders
- 346
- Value change
- -$46,251,906
- Number of buys
- 164
- Number of sells
- 192
Report period
Q1 2020
Institutions
346
Top holders
10
SRPT full security history
Newer quarter: Q2 2020
Previous quarter: Q4 2019
Sarepta Therapeutics, Inc. SEC filings
Sarepta Therapeutics, Inc. company facts
Sarepta Therapeutics, Inc. 13D/G history
Broader feeds
Reporting periods
Holder history for CUSIP 803607100
Recent filing periods:
Top shareholders of SRPT - Sarepta Therapeutics, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| FMR LLC |
13F
|
Company |
7.8%
|
8,177,245
|
$1,055,192,000 | — | 31 Dec 2019 | |
| VANGUARD GROUP INC |
13F
|
Company |
6.1%
|
6,384,788
|
$823,893,000 | — | 31 Dec 2019 | |
| BlackRock Finance, Inc. |
13F
|
Company |
4.4%
|
4,640,285
|
$598,783,000 | — | 31 Dec 2019 | |
| SANDS CAPITAL MANAGEMENT, LLC |
13F
|
Company |
4.3%
|
4,557,499
|
$588,100,000 | — | 31 Dec 2019 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
3.2%
|
3,321,904
|
$428,658,000 | — | 31 Dec 2019 | |
| JANUS HENDERSON GROUP PLC |
13F
|
Company |
3%
|
3,170,682
|
$409,145,000 | — | 31 Dec 2019 | |
| Capital Research Global Investors |
13F
|
Company |
2.3%
|
2,409,053
|
$310,864,000 | — | 31 Dec 2019 | |
| STATE STREET CORP |
13F
|
Company |
1.9%
|
2,018,411
|
$260,456,000 | — | 31 Dec 2019 | |
| Invesco Ltd. |
13F
|
Company |
1.7%
|
1,804,853
|
$232,898,000 | — | 31 Dec 2019 | |
| Avoro Capital Advisors LLC |
13F
|
Company |
1.7%
|
1,760,000
|
$227,110,000 | — | 31 Dec 2019 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
1.3%
|
1,401,305
|
$180,830,000 | — | 31 Dec 2019 | |
| Bank of New York Mellon Corp |
13F
|
Company |
1.1%
|
1,154,181
|
$148,936,000 | — | 31 Dec 2019 | |
| WADDELL & REED FINANCIAL INC |
13F
|
Company |
1.1%
|
1,135,971
|
$146,586,000 | — | 31 Dec 2019 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
1.1%
|
1,108,520
|
$143,044,000 | — | 31 Dec 2019 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
1%
|
1,087,330
|
$140,309,000 | — | 31 Dec 2019 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.95%
|
997,391
|
$128,700,000 | — | 31 Dec 2019 | |
| EVENTIDE ASSET MANAGEMENT, LLC |
13F
|
Company |
0.95%
|
996,000
|
$128,524,000 | — | 31 Dec 2019 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
0.91%
|
951,134
|
$122,733,000 | — | 31 Dec 2019 | |
| GILDER GAGNON HOWE & CO LLC |
13F
|
Company |
0.9%
|
943,811
|
$121,789,000 | — | 31 Dec 2019 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.89%
|
937,350
|
$120,958,000 | — | 31 Dec 2019 | |
| FRED ALGER MANAGEMENT, LLC |
13F
|
Company |
0.82%
|
864,123
|
$111,506,000 | — | 31 Dec 2019 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.75%
|
786,810
|
$101,432,000 | — | 31 Dec 2019 | |
| JENNISON ASSOCIATES LLC |
13F
|
Company |
0.73%
|
770,011
|
$99,362,000 | — | 31 Dec 2019 | |
| ORBIMED ADVISORS LLC |
13F
|
Company |
0.73%
|
766,049
|
$98,851,000 | — | 31 Dec 2019 | |
| Casdin Capital, LLC |
13F
|
Company |
0.64%
|
670,000
|
$86,457,000 | — | 31 Dec 2019 | |
| RTW INVESTMENTS, LP |
13F
|
Company |
0.58%
|
605,762
|
$78,168,000 | — | 31 Dec 2019 | |
| Camber Capital Management LP |
13F
|
Company |
0.57%
|
600,000
|
$77,424,000 | — | 31 Dec 2019 | |
| FIRST TRUST ADVISORS LP |
13F
|
Company |
0.57%
|
598,968
|
$77,291,000 | — | 31 Dec 2019 | |
| NORGES BANK |
13F
|
Company |
0.55%
|
576,123
|
$74,343,000 | — | 31 Dec 2019 | |
| Erste Asset Management GmbH |
13F
|
Company |
0.54%
|
570,260
|
$73,562,216 | — | 31 Dec 2019 | |
| CADIAN CAPITAL MANAGEMENT, LP |
13F
|
Company |
0.52%
|
550,000
|
$70,972,000 | — | 31 Dec 2019 | |
| Artisan Partners Limited Partnership |
13F
|
Company |
0.49%
|
519,895
|
$67,087,000 | — | 31 Dec 2019 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.48%
|
509,153
|
$65,699,000 | — | 31 Dec 2019 | |
| PICTET ASSET MANAGEMENT LTD |
13F
|
Company |
0.48%
|
507,379
|
$65,472,000 | — | 31 Dec 2019 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
0.43%
|
455,636
|
$58,795,000 | — | 31 Dec 2019 | |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC |
13F
|
Company |
0.43%
|
451,473
|
$58,258,075 | — | 31 Dec 2019 | |
| EAGLE ASSET MANAGEMENT INC |
13F
|
Company |
0.42%
|
443,451
|
$57,222,000 | — | 31 Dec 2019 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.42%
|
438,341
|
$56,564,000 | — | 31 Dec 2019 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.4%
|
416,757
|
$53,779,000 | — | 31 Dec 2019 | |
| CREDIT SUISSE AG/ |
13F
|
Company |
0.4%
|
416,171
|
$53,704,000 | — | 31 Dec 2019 | |
| FIL Ltd |
13F
|
Company |
0.39%
|
410,972
|
$53,032,000 | — | 31 Dec 2019 | |
| Sumitomo Mitsui Trust Group, Inc. |
13F
|
Company |
0.38%
|
404,238
|
$52,163,000 | — | 31 Dec 2019 | |
| Consonance Capital Management LP |
13F
|
Company |
0.34%
|
356,145
|
$45,957,000 | — | 31 Dec 2019 | |
| Rock Springs Capital Management LP |
13F
|
Company |
0.33%
|
345,500
|
$44,583,000 | — | 31 Dec 2019 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
0.33%
|
344,710
|
$44,481,000 | — | 31 Dec 2019 | |
| CARILLON TOWER ADVISERS, INC. |
13F
|
Company |
0.32%
|
339,743
|
$43,840,437 | — | 31 Dec 2019 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.31%
|
330,791
|
$42,686,000 | — | 31 Dec 2019 | |
| WESTFIELD CAPITAL MANAGEMENT CO LP |
13F
|
Company |
0.31%
|
326,278
|
$42,103,000 | — | 31 Dec 2019 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.28%
|
290,404
|
$37,474,000 | — | 31 Dec 2019 | |
| MORGAN STANLEY |
13F
|
Company |
0.28%
|
289,429
|
$37,349,000 | — | 31 Dec 2019 |
Institutional Holders of Sarepta Therapeutics, Inc. - Common Stock (SRPT) as of Q1 2020
As of 31 Mar 2020,
Sarepta Therapeutics, Inc. - Common Stock (SRPT) was held by
346 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
73,412,115 shares.
The largest 10 holders included
FMR LLC, VANGUARD GROUP INC, BlackRock Inc., SANDS CAPITAL MANAGEMENT, LLC, Capital Research Global Investors, JANUS HENDERSON GROUP PLC, STATE STREET CORP, ADAGE CAPITAL PARTNERS GP, L.L.C., PRICE T ROWE ASSOCIATES INC /MD/, and AMERIPRISE FINANCIAL INC.
This page lists
346
institutional shareholders reporting positions in this security
for the Q1 2020 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2020 vs Q4 2019 Across Filers
Q4 2019 holders
379
Q1 2020 holders
346
Holder diff
-33
| Investor | Q4 2019 Shares | Q1 2020 Shares | Share Diff | Share Chg % | Q4 2019 Value $ | Q1 2020 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.